Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Dermatol ; 24(3): 316-7, 2007.
Article in English | MEDLINE | ID: mdl-17542889

ABSTRACT

We report an extremely unusual instance of macular erythema on the arms of a 15-year-old boy that occurs when the arms are in a dependent position. The eruption disappears promptly on elevation of the arms. The skin changes observed in our patient are similar to those previously described under the term gravitational erythema. It is suggested that the cutaneous lesions are secondary to an abnormal response to changes in venous pressure.


Subject(s)
Arm/physiopathology , Erythema/physiopathology , Posture/physiology , Adolescent , Gravitation , Humans , Male , Venous Pressure/physiology
2.
Int J Dermatol ; 45(7): 822-7, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16863519

ABSTRACT

BACKGROUND: Modifications in social habits together with the increase of emigration have contributed not only to increased dermatophytoses but also to an altered etiology. During the last few years, Braga has suffered a radical change from a rural to a cosmopolitan life-style. METHODS: A statistical study of dermatophytoses and the etiology of their causative agents was performed by a retrospective survey carried out among patients of Hospital de São Marcos, Braga, Portugal, from 1983-2002. In this study, a total of 10,003 patients were analyzed. RESULTS: Over this period the frequency of dermatophytoses, as defined by the recovery of a dermatophyte in culture, was found to be 23.6%, whereas nondermatophytic infections accounted for 7.0%. Analysis of the clinical forms and the isolated fungi supports that the dermatophyte species have a predilection for certain body areas (P

Subject(s)
Dermatomycoses/epidemiology , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Child , Child, Preschool , Dermatomycoses/diagnosis , Dermatomycoses/microbiology , Female , Health Surveys , Humans , Infant , Male , Middle Aged , Portugal/epidemiology , Retrospective Studies , Sex Distribution
3.
J Eur Acad Dermatol Venereol ; 20(6): 651-6, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16836490

ABSTRACT

Though used occasionally, systemic therapies in severe childhood psoriasis have not been systematically investigated. Cyclosporin A (CysA) is effective in adults with severe psoriasis but there are no extensive data regarding the efficacy and safety of its use in childhood psoriasis. In this paper, we describe six children aged between 11 months and 13 years (average: 7.6 years) treated with CysA microemulsion formulation for severe psoriasis, who had been unresponsive to other treatments. The CysA dose ranged from 2 to 4 mg/kg/day, for periods varying from 8 to 105 weeks (mean: 54 weeks). Dose tapering was gradual after lesion improvement and adjusted according to clinical response. Adjuvant therapy with topical steroids, vitamin D3 ointments, coal tar preparations or anthralin was used in all children. Acitretin was used in three patients for short periods. The children were regularly monitored for serum renal and liver function and blood pressure. Improvement of skin lesions was achieved after between 4 and 30 (mean: 12) weeks of treatment, with complete remission in three children. Relapse of lesions occurred in the other children during CysA reduction, but they responded to a dose increase. The treatment was found to be well tolerated and with no significant side-effects. CysA can be used in carefully selected and monitored patients and may represent an alternative tool for severe episodes of psoriasis in children, when other therapies are unsuccessful.


Subject(s)
Cyclosporine/therapeutic use , Dermatologic Agents/therapeutic use , Psoriasis/drug therapy , Adolescent , Child , Child, Preschool , Cyclosporine/adverse effects , Dermatologic Agents/adverse effects , Female , Humans , Infant , Male , Severity of Illness Index , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...